The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in ... inhaled COPD medicines. All the patients also had lung inflammation confirmed by ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Breathe easier and live healthier by including these expert-recommended lifestyle changes into your daily routine to ...

Lung disease affects around 1 in 7 older persons, making it a serious health risk. Among persons 60 years of age and older, ...

COPD is a deadly lung condition that makes it almost impossible to breathe! It can also rupture the airways posing a threat ...

Dupixent becomes the first biologic treatment for COPD in the U.S. COPD is a long-term lung disease that makes breathing difficult and gets worse over time. It accounts for most deaths from ...

"The disease COPD is frequently characterized or described as being a disease where lung function is irreversibly damaged," Rabe explained in an interview with The American Journal of Managed Care ...

Dr Lambert says people often put lung problems down to something else, rather than getting potentially serious signs checked.

Patients considered as having pre-COPD or PRISm have a ... due to the loss of elastic lung recoil as a consequence of emphysema) and/or during exercise (dynamic hyperinflation as a consequence ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...